Degradation of MCL-1 by bufalin reverses acquired resistance to osimertinib in EGFR-mutant lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Degradation of MCL-1 by bufalin reverses acquired resistance to osimertinib in EGFR-mutant lung cancer

Published:2019-09 Issue: Volume:379 Page:114662
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Cao Fei,Gong Ya-Bin,Kang Xiao-Hong,Lu Zhi-Hong,Wang Ying,Zhao Ke-Lei,Miao Zhan-Hui,Liao Ming-Juan,Xu Zhen-Ye

Funder

National Natural Science Foundation of China

Project of scientific research and innovation of Shanghai Education Commission

Shanghai Science and Technology Commission

Youth Foundation of First Affiliated Hospital of Xinxiang Medical University

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference48 articles.

1. Humanized Mcl-1 mice enable accurate preclinical evaluation of MCL-1 inhibitors destined for clinical use;Brennan;Blood,2018

2. Role of non-homologous end joining (NHEJ) in maintaining genomic integrity;Burma;DNA Repair (Amst),2006

3. MCL-1 is a prognostic indicator and drug target in breast cancer;Campbell;Cell Death Dis.,2018

4. Anti-hepatitis B virus activities of cinobufacini and its active components bufalin and cinobufagin in HepG2.2.15 cells;Cui;Biol. Pharm. Bull.,2010

5. Bufalin and 5-fluorouracil synergistically induce apoptosis in colorectal cancer cells;Dai;Oncol. Lett.,2018

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combinational Antitumor Strategies Based on the Active Ingredients of Toad Skin and Toad Venom;Drug Design, Development and Therapy;2024-08

2. MicroRNA-29b-3p reduces cisplatin resistance in non-small cell lung cancer by targeting myeloid cell leukemia-1;Molecular & Cellular Toxicology;2024-04-12

3. Chemical Composition, Pharmacological Effects and Clinical Applications of Cinobufacini;Chinese Journal of Integrative Medicine;2024-01-12

4. Pan-EGFR Inhibitor Dacomitinib Resensitizes Paclitaxel and Induces Apoptosis via Elevating Intracellular ROS Levels in Ovarian Cancer SKOV3-TR Cells;Molecules;2024-01-04

5. Research Status of Anti-Aging Drugs in Non-Small Cell Lung Cancer;Advances in Clinical Medicine;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3